Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Клинический обзор: сердечно-сосудистые заболевания при сахарном диабете
2016-06-13
SCID: 54.1/t3qh5kjf
Discuss with AI
atherosclerosiscardiovascular diseasecardiovascular risk reductiondiabetes mellitusheart failure
Figures from the paper
Abstract (AI)
Cardiovascular disease remains the principal cause of death and disability among patients with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying atherosclerosis and heart failure. Unfortunately, these mechanisms are not adequately modulated by therapeutic strategies focusing solely on optimal glycemic control with currently available drugs or approaches. In the setting of multifactorial risk reduction with statins and other lipid-lowering agents, antihypertensive therapies, and antihyperglycemic treatment strategies, cardiovascular complication rates are falling, yet remain higher for patients with diabetes mellitus than for those without. This review considers the mechanisms, history, controversies, new pharmacological agents, and recent evidence for current guidelines for cardiovascular management in the patient with diabetes mellitus to support evidence-based care in the patient with diabetes mellitus and heart disease outside of the acute care setting.
Key Findings
1
Cardiovascular disease remains the leading cause of death and disability among patients with diabetes mellitus.
2
Diabetes mellitus accelerates mechanisms contributing to both atherosclerosis and heart failure.
3
Multifactorial risk reduction with lipid-lowering, antihypertensive, and antihyperglycemic therapies lowers cardiovascular complication rates, but rates remain higher than in people without diabetes.
4
Strategies focused solely on glycemic control do not adequately modulate the cardiovascular mechanisms associated with diabetes.
5
The review synthesizes mechanisms, controversies, newer pharmacological agents, and guideline evidence to support cardiovascular management of diabetes-associated heart disease outside acute care settings.
Research Object
cardiovascular disease in patients with diabetes mellitus
Research Subject
the mechanisms, risk-reduction strategies, pharmacological treatments, and evidence-based management of cardiovascular complications, including atherosclerosis and heart failure, in diabetes mellitus
Publication Details
Publication Date
2016-06-13
Journal
Publisher
ISSN
Cited by
1183
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai13
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus1993
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002
2013 ACCF/AHA Guideline for the Management of Heart Failure2013
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)2012
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 20122012
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
European guidelines on cardiovascular disease prevention in clinical practice: executive summary2007
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes2014
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2013
Nutrition Therapy Recommendations for the Management of Adults With Diabetes2013